Atlanta Business Chronicle -- The bloodletting in Atlanta’s pharma industry continues. Stiefel Laboratories Inc. said it will shutter its 200-plus employee Duluth operations and move the work to Research Triangle Park, N.C., months after being acquired by United Kingdom-based GlaxoSmithKline Plc.
